The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma.
In this study, the safety and efficacy of buntanetap will be assessed in a diverse population of early AD participants via a randomized, double-blind, placebo-controlled, multicenter Phase 3 trial.
The purpose of this research is to learn if the experimental study drug KarXT + KarX-EC works to treat thinking and memory problems as well as improve overall function in people with Alzheimer’s disease (AD).
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
